The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
All good points!
Tomorrow will be an interesting day, US markets ran out of steam in the last 2 hours of trading, and failed to crack the 3155 resistance level (3rd time!!). But I’m guessing (hoping) this may be due to the long weekend and cash being held back, of course if we hadn’t seen 50k cases - the jobs report would’ve had the markets flying again.
This isn’t based on any medical evidence - just numbers - but I *think* this may be the worst of it (55-65k cases). If cases begin to drop, I can’t see the markets holding back!! :D
Cheers Damo, will take a look. Early indications, especially against such small numbers are always going to be shaky but thats why I'm eager to see the results of phase 3 when they finally get published. I like the theory behind targeting the spikes of the virus which is the part that hasn't been mutating significantly preventing the virus from having the tools to infect cells. If they've done it right it could end up being a very strong weapon in the fight of covid-19.
pumpky, every time WINK
Lin to the "COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)" -> https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
If you're interested.
Big share sale and sp goes up!!
I pooh-pooh'd the report about the recent vaccine news... The report said a test on approx 50 people and 24 had been responsive. You could test anything on these people and have an equal chance at getting the same result. The trial numbers are just too low to mean anything at all.
Check out https://www.thelancet.com/coronavirus for some decent information - it's a well respected scientific journal. I'm sure you'll find something of interest.
I'm just curious how long we need to wait for results from phase 3.
https://www.nasdaq.com/articles/oxford-university-has-seen-right-sort-of-immune-response-in-potential-covid-19-vaccine